Molecules
Small-Molecule NANT Therapeutics Targeting the Brain-Immune Axis in Alzheimer's Disease: Mechanisms, Clinical Progress, and Translational Challenges
ReviewInterventions
Abstract
Alzheimer's disease (AD) is now widely accepted as a complex disorder involving multiple interconnected pathological processes.
